SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-017950
Filing Date
2022-07-28
Accepted
2022-07-28 08:00:27
Documents
13
Period of Report
2022-07-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20220727_8k.htm   iXBRL 8-K 32329
  Complete submission text file 0001437749-22-017950.txt   166478

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20220727.xsd EX-101.SCH 3602
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20220727_def.xml EX-101.DEF 11533
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20220727_lab.xml EX-101.LAB 15415
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20220727_pre.xml EX-101.PRE 11689
7 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20220727_8k_htm.xml XML 2558
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 221112855
SIC: 2836 Biological Products, (No Diagnostic Substances)